Although the formation of collaterals is classically regarded as a compensatory mechanism to bypass and thus alleviate an obstruction, the mechanism and inducement of collateral formation are unknown.

LAS VEGAS, NV—A self-expanding nitinol stent is effective for the treatment of venous obstructions in the iliac and femoral veins, according to 12-month data from the nonrandomized, multicenter ...

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz., Jan. 6, 2026 ...

Abre (Medtronic), a dedicated venous stent, has a 12-month primary patency rate of 88%, exceeding the performance goal for effectiveness in its pivotal investigational device exemption (IDE) trial.

Narrowing or blockage of your veins is the principal cause of this problem, which can be life threatening. Fortunately, there is a relatively quick, safe, and effective way to treat this condition by ...

DUBLIN, Oct. 26, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and freedom from target lesion ...

Please provide your email address to receive an email when new articles are posted on . According to a retrospective study, iliac vein compression appears to be a promoter of, but not a cause of, ...

Veniti started its 200-person trial of the Vici Venous Stent System on Dec. 1. Now it's got more than $17 million to complete that trial that is targeting a U.S. approval to treat venous disease. The ...

Iliac venous outflow obstruction has an important role in the expression of symptomatic chronic venous insufficiency. This anatomic obstruction is frequently overlooked, owing in part to diagnostic ...